What is the average price target for PEPGEN INC (PEPG) stock?
13 analysts have analysed PEPG and the average price target is 10.37 USD. This implies a price increase of 112.07% is expected in the next year compared to the current price of 4.89.
NASDAQ:PEPG • US7133171055
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PEPGEN INC (PEPG).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-25 | Oppenheimer | Initiate | Outperform |
| 2026-02-18 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-30 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-25 | Stifel | Maintains | Buy -> Buy |
| 2025-09-25 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-24 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-09-09 | Guggenheim | Initiate | Buy |
| 2025-05-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-18 | B of A Securities | Maintains | Neutral -> Neutral |
| 2024-11-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-31 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-15 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-01-30 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-09-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 109.30% | N/A 121.26% | N/A 47.06% | N/A -17.17% | ||||||||
| EBITDA YoY % growth | -1.24M | -1.77M -42.74% | -26.93M -1,421.47% | -67.81M -151.80% | -83.582M -23.26% | -96.234M -15.14% | -92.215M 4.18% | N/A -17.93% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.35M | -1.88M -39.26% | -27.11M -1,342.02% | -68.3M -151.94% | -84.766M -24.11% | -97.739M -15.30% | -93.612M 4.22% | N/A -4.42% | N/A -5.84% | N/A -14.50% | N/A 66.64% | N/A 208.73% | N/A 410.41% | N/A 72.17% | N/A -26.15% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -21.20 | -3.30 84.43% | -2.84 13.88% | -2.41 15.20% | N/A 43.77% | N/A 17.51% | N/A 44.80% | N/A 144.63% | N/A 242.59% | N/A 251.35% | N/A -12.62% | N/A 24.47% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 66.07% | -0.36 48.64% | -0.33 36.25% | -0.34 -24.67% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -21.522M 30.42% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.843M 33.45% | -21.406M 10.56% | -22.111M -18.53% | -22.917M -16.30% |
All data in USD
13 analysts have analysed PEPG and the average price target is 10.37 USD. This implies a price increase of 112.07% is expected in the next year compared to the current price of 4.89.
PEPGEN INC (PEPG) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of PEPGEN INC (PEPG) is -0.31 USD and the consensus revenue estimate is 0 USD.
The number of analysts covering PEPGEN INC (PEPG) is 13.